Chondroplasty Market Report 2026
Global Outlook – By Type (Radiofrequency Ablation Chondroplasty, Abrasion Chondroplasty, Patellar Chondroplasty, Tissue Removal, Other Types), By Anatomy (Knee, Shoulder, Hip, Other Anatomies), By Equipment (Shavers, Radiofrequency Devices, Arthroscope, Other Equipments), By End Use (Hospitals, Orthopedic Clinics, Academic Research, Other End Uses) - Market Size, Trends, Strategies, and Forecast to 2030
Chondroplasty Market Overview
• Chondroplasty market size has reached to $14.62 billion in 2025 • Expected to grow to $19.77 billion in 2030 at a compound annual growth rate (CAGR) of 6.4% • Growth Driver: Growing Incidence Of Joint-Related Disorders Fuels Chondroplasty Market Expansion • Market Trend: Innovative Autologous Chondrocyte Therapies Revolutionizing Cartilage Repair in Chondroplasty Market • North America was the largest region in 2025.What Is Covered Under Chondroplasty Market?
Chondroplasty is a surgical method that involves repairing and reshaping the damaged cartilage within a joint. It is typically performed to alleviate pain and improve joint function, often in cases of cartilage damage due to conditions such as osteoarthritis or traumatic injuries. The main types of chondroplasty are radiofrequency ablation chondroplasty, abrasion chondroplasty, atellar chondroplasty, meniscal repair, tissue removal, and others. Radiofrequency ablation chondroplasty refers to the procedure that targets minor imperfections in knee cartilage to minimize joint deterioration. The various anatomies are knee, shoulder, hip, and others with shavers, radiofrequency devices, arthroscope, and others. The end users are hospitals, orthopedic clinics, academic research, and others.
What Is The Chondroplasty Market Size and Share 2026?
The chondroplasty market size has grown strongly in recent years. It will grow from $14.62 billion in 2025 to $15.44 billion in 2026 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to increasing incidence of osteoarthritis, rising sports-related joint injuries, expansion of orthopedic surgical infrastructure, growing acceptance of arthroscopic procedures, availability of advanced surgical tools.What Is The Chondroplasty Market Growth Forecast?
The chondroplasty market size is expected to see strong growth in the next few years. It will grow to $19.77 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing aging population with joint disorders, rising preference for minimally invasive orthopedic treatments, expansion of sports medicine services, growing adoption of advanced cartilage repair technologies, increasing investment in orthopedic surgical innovation. Major trends in the forecast period include increasing adoption of minimally invasive cartilage repair procedures, rising use of radiofrequency ablation techniques, growing demand for arthroscopic chondroplasty devices, expansion of outpatient orthopedic surgeries, enhanced focus on joint preservation treatments.
Global Chondroplasty Market Segmentation
1) By Type: Radiofrequency Ablation Chondroplasty, Abrasion Chondroplasty, Patellar Chondroplasty, Tissue Removal, Other Types 2) By Anatomy: Knee, Shoulder, Hip, Other Anatomies 3) By Equipment: Shavers, Radiofrequency Devices, Arthroscope, Other Equipments 4) By End Use: Hospitals, Orthopedic Clinics, Academic Research, Other End Uses Subsegments: 1) By Radiofrequency Ablation Chondroplasty: High-Frequency Ablation, Low-Frequency Ablation 2) By Abrasion Chondroplasty: Mechanical Abrasion, Arthroscopic Abrasion 3) By Patellar Chondroplasty: Open Patellar Chondroplasty, Arthroscopic Patellar Chondroplasty 4) By Tissue Removal: Arthroscopic Debridement, Open Debridement 5) By Other Types: Microfracture Techniques, Osteochondral Autograft TransplantationWhat Is The Driver Of The Chondroplasty Market?
The rising incidence of joint-related disorders is expected to propel the growth of the chondroplasty market going forward. Joint disorders are diseases that affect the health and function of a joint caused by overuse of a joint or a sudden injury, such as an accident or a sports injury. Chondroplasty treats joint-related disorders by repairing the damaged cartilage in a joint. For instance, in February 2025, Arthritis Australia, Australia-Based non-profit organization, the study estimates that approximately 5.39 million Australians will be living with arthritis, representing a 31% increase since 2025. Therefore, the rising incidence of joint-related disorders is driving the growth of the chondroplasty industry going forward.Key Players In The Global Chondroplasty Market
Major companies operating in the chondroplasty market are Johnson & Johnson, Osiris Therapeutics Inc., Medtronic Public Limited Company, Stryker Corporation, B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Arthrex Inc., CONMED Corporation, Organogenesis Holdings Inc., Bioventus LLC, RTI Surgical Holdings Inc., Vericel Corporation, Geistlich Pharma AG, MEDIPOST Co. Ltd., GPC Medical Ltd., Sklar Surgical Instruments, Isto Biologics, NuOrtho Surgical Inc., Medical Devices Business Services Inc.
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.
This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Explore how leading companies compare across key metrics in our report Get Report
Global Chondroplasty Market Trends and Insights
Major companies operating in the chondroplasty market are developing autologous chondrocytes to enhance cartilage repair by utilizing the patient's own cells, which reduces immune rejection and promotes natural regeneration. Autologous chondrocytes are cartilage cells taken from a patient’s own body, typically harvested from a non-weight-bearing area of the joint. For instance, in August 2024, Vericel Corporation, a US-based biopharmaceutical company, received FDA approval and commercial availability of MACI Arthro (Matrix Autologous Chondrocyte Implantation), a significant advancement in the treatment of cartilage defects in the knee. MACI Arthro allows orthopedic surgeons to perform the procedure through small incisions using specially designed instruments, which is less invasive compared to traditional methods. This approach is expected to enhance patient recovery and reduce post-operative complications.What Are Latest Mergers And Acquisitions In The Chondroplasty Market?
In July 2023, Avanos Medical Inc., a US-based provider of therapies and solutions for pain management and chronic care, acquired Diros Technology Inc. for $60 million. This acquisition enhances Avanos' position as the industry leader in RF technology by offering a broad line of superior, unique pain treatment devices. Diros Technology Inc. is a Canada-based manufacturer of radiofrequency devices for joint disorders such as knee, cervical, and lumbar pain.
Regional Outlook
North America was the largest region in the chondroplasty market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.Need data for a specific geography? Request Regional Data
What Defines the Chondroplasty Market?
The chondroplasty market includes revenues earned by entities by providing services such as microfracture surgery, laser-assisted treatments, and autologous chondrocyte transplantation (ACT). The market value includes the value of related goods sold by the service provider or included within the service offering. The chondroplasty market also includes sales of radiofrequency ablation devices and autologous chondrocyte implants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.
This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
Access full TAM calculations and growth projections in our report Get Report
What Key Data and Analysis Are Included in the Chondroplasty Market Report 2026?
The chondroplasty market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the chondroplasty industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Chondroplasty Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $15.44 billion |
| Revenue Forecast In 2030 | $19.77 billion |
| Growth Rate | CAGR of 6.4% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Type, Anatomy, Equipment, End Use |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain |
| Key Companies Profiled | Johnson & Johnson, Osiris Therapeutics Inc., Medtronic Public Limited Company, Stryker Corporation, B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Arthrex Inc., CONMED Corporation, Organogenesis Holdings Inc., Bioventus LLC, RTI Surgical Holdings Inc., Vericel Corporation, Geistlich Pharma AG, MEDIPOST Co. Ltd., GPC Medical Ltd., Sklar Surgical Instruments, Isto Biologics, NuOrtho Surgical Inc., Medical Devices Business Services Inc. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |